Abeona Therapeutics Inc. SEC filings ABEO

Abeona Therapeutics Inc. has 1,000 filings in SEC EDGAR's recent list, going back to Oct 21, 2008. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 13, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.

Abeona Therapeutics Inc. SEC filings
Form Description Filed Period
8-K Current report
Regulation FD disclosure
Sep 15, 2026 Sep 15, 2026
10-Q Quarterly report Aug 13, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 13, 2026 Aug 13, 2026
424B3 Prospectus Jul 10, 2026 —
S-8 Employee stock plan registration Jun 26, 2026 —
8-K Current report
Shareholder vote results
Jun 12, 2026 Jun 12, 2026
8-K Current report
Officer or director change
Jun 12, 2026 Jun 11, 2026
8-K Current report
Regulation FD disclosure
Jun 10, 2026 Jun 10, 2026
8-K Current report
Other events
Jun 4, 2026 Jun 3, 2026
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 13, 2026 May 13, 2026
DEFA14A Additional proxy material May 4, 2026 —
ARS Annual report to shareholders Apr 27, 2026 Dec 31, 2025
DEF 14A Proxy statement Apr 27, 2026 Apr 27, 2026
PRE 14A Preliminary proxy statement Apr 17, 2026 Apr 17, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 7, 2026 Apr 1, 2026
8-K Current report
Bylaw or fiscal year change
Mar 20, 2026 Mar 16, 2026
10-K Annual report Mar 17, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 17, 2026 Mar 17, 2026
8-K Current report
Other events
Mar 9, 2026 Mar 9, 2026
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
10-Q Quarterly report Aug 14, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 14, 2025 Aug 14, 2025
8-K Current report
Material agreement, New debt
Jul 18, 2025 Jul 18, 2025
8-K Current report
Acquisition or sale of assets, Results of operations, Other events
Jul 2, 2025 Jun 27, 2025
8-K Current report
Shareholder vote results
May 19, 2025 May 19, 2025
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 15, 2025 May 15, 2025
8-K Current report
Material agreement, Other events
May 12, 2025 May 9, 2025
8-K Current report
Regulation FD disclosure
Apr 29, 2025 Apr 29, 2025
8-K Current report
Other events
Apr 29, 2025 Apr 29, 2025
DEF 14A Proxy statement Apr 9, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 20, 2025 Mar 20, 2025
10-K Annual report Mar 20, 2025 Dec 31, 2024
S-8 Employee stock plan registration Jan 6, 2025 —
8-K Current report
Officer or director change, Shareholder vote results
Dec 20, 2024 Dec 20, 2024
10-Q Quarterly report Nov 14, 2024 Sep 30, 2024
8-K Current report
Results of operations
Nov 14, 2024 Nov 14, 2024
DEF 14A Proxy statement Nov 12, 2024 Nov 12, 2024
8-K Current report
Other events
Nov 12, 2024 Nov 8, 2024
8-K Current report
Other events
Oct 29, 2024 Oct 28, 2024
8-K Current report
Officer or director change
Aug 14, 2024 Aug 8, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations
Aug 12, 2024 Aug 12, 2024
8-K Current report
Bylaw or fiscal year change
Jul 9, 2024 Jul 5, 2024
424B5 Prospectus supplement Jun 21, 2024 —
EFFECT Filing Jun 20, 2024 —
CORRESP Letter to the SEC Jun 17, 2024 —
S-3/A Filing Jun 17, 2024 —
S-3 Shelf registration Jun 12, 2024 —
S-8 Employee stock plan registration May 15, 2024 —
10-Q Quarterly report May 15, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 15, 2024 May 15, 2024
8-K Current report
Material agreement, Other events
May 3, 2024 May 3, 2024
424B5 Prospectus supplement May 3, 2024 —
8-K Current report
Results of operations, Other events
May 3, 2024 May 2, 2024
8-K Current report
Officer or director change, Shareholder vote results
Apr 24, 2024 Apr 24, 2024
8-K Current report
Other events
Apr 22, 2024 Apr 22, 2024
DEF 14A Proxy statement Mar 19, 2024 Mar 19, 2024
8-K Current report
Results of operations
Mar 18, 2024 Mar 18, 2024
10-K Annual report Mar 18, 2024 Dec 31, 2023
8-K Current report
Material agreement, New debt, Other events
Jan 8, 2024 Jan 8, 2024
8-K Current report
Other events
Nov 27, 2023 Nov 27, 2023
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations
Nov 13, 2023 Nov 13, 2023
8-K Current report
Auditor change
Oct 18, 2023 Oct 16, 2023
S-8 Employee stock plan registration Oct 10, 2023 —
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Other events
Jul 7, 2023 Jul 7, 2023
8-K Current report
Material agreement, Other events
Jul 3, 2023 Jul 3, 2023
424B5 Prospectus supplement Jul 3, 2023 —
424B5 Prospectus supplement Jun 7, 2023 —
S-8 Employee stock plan registration May 19, 2023 —
8-K Current report
Shareholder vote results
May 17, 2023 May 17, 2023
10-Q Quarterly report May 11, 2023 Mar 31, 2023
8-K Current report
Results of operations
May 11, 2023 May 11, 2023
ARS Annual report to shareholders Apr 19, 2023 Dec 31, 2022
DEF 14A Proxy statement Apr 13, 2023 Apr 13, 2023
8-K Current report
Officer or director change
Apr 11, 2023 Apr 6, 2023
10-K/A Amended annual report Apr 10, 2023 Dec 31, 2022
424B5 Prospectus supplement Mar 29, 2023 —
8-K Current report
Results of operations
Mar 29, 2023 Mar 29, 2023
10-K Annual report Mar 29, 2023 Dec 31, 2022
S-8 Employee stock plan registration Mar 22, 2023 —
8-K Current report
Regulation FD disclosure
Mar 13, 2023 Mar 13, 2023
EFFECT Filing Dec 12, 2022 —
CORRESP Letter to the SEC Dec 6, 2022 —
UPLOAD Letter from the SEC Dec 5, 2022 —
S-3 Shelf registration Dec 1, 2022 —
10-Q Quarterly report Nov 14, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 14, 2022 Nov 14, 2022
8-K Current report
Material agreement, Unregistered share sale, Other events
Nov 3, 2022 Nov 3, 2022
8-K Current report
Regulation FD disclosure, Other events
Nov 3, 2022 Nov 3, 2022
424B5 Prospectus supplement Oct 12, 2022 —
S-8 Employee stock plan registration Aug 31, 2022 —
8-K Current report
Shareholder vote results
Aug 17, 2022 Aug 17, 2022
10-Q Quarterly report Aug 11, 2022 Jun 30, 2022
8-K Current report
Results of operations
Aug 11, 2022 Aug 11, 2022
DEFA14A Additional proxy material Aug 4, 2022 —
8-K Current report
Other events
Jul 20, 2022 Jul 19, 2022
424B5 Prospectus supplement Jul 19, 2022 —
DEF 14A Proxy statement Jul 11, 2022 Aug 17, 2022
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 30, 2022 Jun 30, 2022
8-K Current report
Shareholder vote results
Jun 14, 2022 Jun 14, 2022
8-K Current report
Listing notice, Regulation FD disclosure
May 19, 2022 May 17, 2022
8-K Current report
Material agreement, Regulation FD disclosure
May 17, 2022 May 16, 2022
10-Q Quarterly report May 13, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 13, 2022 May 13, 2022
DEF 14A Proxy statement May 12, 2022 Jun 14, 2022
PRE 14A Preliminary proxy statement May 2, 2022 Jun 14, 2022
8-K Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Other events
May 2, 2022 Apr 29, 2022
8-K Current report
Bylaw or fiscal year change
Apr 29, 2022 Apr 25, 2022
10-K Annual report Mar 31, 2022 Dec 31, 2021
8-K Current report
Results of operations
Mar 31, 2022 Mar 31, 2022
8-K Current report
Officer or director change
Mar 9, 2022 Mar 3, 2022
8-K Current report
Other events
Dec 17, 2021 Dec 17, 2021
424B5 Prospectus supplement Dec 17, 2021 —
424B5 Prospectus supplement Dec 16, 2021 —
8-K Current report
Other events
Dec 16, 2021 Dec 16, 2021
424B5 Prospectus supplement Nov 19, 2021 —
8-K Current report
Material agreement, Listing notice
Nov 19, 2021 Nov 16, 2021
8-K Current report
Results of operations
Nov 15, 2021 Nov 15, 2021
10-Q Quarterly report Nov 15, 2021 Sep 30, 2021
8-K Current report
Material agreement
Nov 15, 2021 Nov 12, 2021
EFFECT Filing Oct 22, 2021 —
CORRESP Letter to the SEC Oct 19, 2021 —
S-3/A Filing Oct 19, 2021 —
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 21, 2021 Sep 16, 2021
CORRESP Letter to the SEC Aug 30, 2021 —
CORRESP Letter to the SEC Aug 27, 2021 —
S-3/A Filing Aug 27, 2021 —
8-K Current report
Officer or director change
Aug 13, 2021 Aug 10, 2021
8-K Current report
Results of operations
Jul 28, 2021 Jul 28, 2021
10-Q Quarterly report Jul 28, 2021 Jun 30, 2021
8-K Current report
Other events
Jul 16, 2021 Jul 13, 2021
UPLOAD Letter from the SEC Jun 11, 2021 —
S-3 Shelf registration Jun 7, 2021 —
8-K/A Amended current report
Officer or director change
May 28, 2021 Apr 14, 2021
8-K Current report
Shareholder vote results
May 28, 2021 May 26, 2021
8-K Current report
Results of operations, Regulation FD disclosure
May 26, 2021 May 25, 2021
8-K Current report
Results of operations
May 18, 2021 May 18, 2021
10-Q Quarterly report May 17, 2021 Mar 31, 2021
DEFA14A Additional proxy material May 12, 2021 —
DEFR14A Filing Apr 19, 2021 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 19, 2021 Apr 14, 2021
DEF 14A Proxy statement Apr 9, 2021 May 26, 2021
PRE 14A Preliminary proxy statement Mar 30, 2021 Mar 30, 2021
8-K Current report
Officer or director change, Regulation FD disclosure
Mar 30, 2021 Mar 24, 2021
8-K Current report
Results of operations
Mar 24, 2021 Mar 24, 2021
10-K Annual report Mar 24, 2021 Dec 31, 2020
8-K Current report
Officer or director change
Mar 23, 2021 Mar 19, 2021
8-K Current report
Regulation FD disclosure
Feb 12, 2021 Feb 12, 2021
8-K Current report
Officer or director change
Feb 1, 2021 Jan 27, 2021
8-K Current report
Regulation FD disclosure
Jan 25, 2021 Jan 25, 2021
8-K Current report
Officer or director change
Nov 17, 2020 Nov 10, 2020
8-K Current report
Listing notice
Nov 12, 2020 Nov 5, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 30, 2020 Oct 26, 2020
8-K Current report
Material agreement, Officer or director change
Oct 16, 2020 Oct 9, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 6, 2020 Sep 30, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 29, 2020 Sep 23, 2020
8-K Current report
Officer or director change
Sep 17, 2020 Sep 14, 2020
8-K Current report
Results of operations
Aug 10, 2020 Aug 10, 2020
10-Q Quarterly report Aug 10, 2020 Jun 30, 2020
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 23, 2020 Jun 17, 2020
S-8 Employee stock plan registration May 21, 2020 —
8-K Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
May 21, 2020 May 20, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
PX14A6G Filing Apr 29, 2020 —
8-K Current report
Listing notice
Apr 24, 2020 Apr 21, 2020
DEFA14A Additional proxy material Apr 23, 2020 —
8-K Current report
Officer or director change, Regulation FD disclosure
Apr 21, 2020 Apr 15, 2020
DEF 14A Proxy statement Apr 10, 2020 May 20, 2020
8-K Current report
Officer or director change
Apr 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
Mar 16, 2020 Mar 16, 2020
8-K Current report
Officer or director change
Mar 16, 2020 Mar 10, 2020
10-K Annual report Mar 16, 2020 Dec 31, 2019
SEC STAFF LETTER Filing Mar 6, 2020 —
SEC STAFF LETTER Filing Feb 18, 2020 —
8-K Current report
Officer or director change
Jan 8, 2020 Jan 7, 2020
8-K Current report
Officer or director change
Jan 7, 2020 Jan 2, 2020
8-K Current report
Other events
Dec 26, 2019 Dec 20, 2019
8-K Current report
Officer or director change, Other events
Dec 23, 2019 Dec 19, 2019
424B5 Prospectus supplement Dec 23, 2019 —
25-NSE Delisting notice Dec 20, 2019 —
8-K Current report
Other events
Dec 20, 2019 Dec 19, 2019
424B5 Prospectus supplement Dec 20, 2019 —
8-K Current report
Other events
Dec 10, 2019 Dec 9, 2019
8-K Current report
Results of operations
Nov 12, 2019 Nov 12, 2019
10-Q Quarterly report Nov 12, 2019 Sep 30, 2019
8-K Current report
Material agreement
Nov 7, 2019 Nov 1, 2019
UPLOAD Letter from the SEC Sep 24, 2019 —
8-K Current report
Other events
Sep 23, 2019 Sep 23, 2019
CORRESP Letter to the SEC Sep 20, 2019 —
8-K Current report
Officer or director change, Bylaw or fiscal year change
Sep 18, 2019 Sep 12, 2019
UPLOAD Letter from the SEC Sep 18, 2019 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ABEO (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Cleveland, OH
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
318306
Former names
PLASMATECH BIOPHARMACEUTICALS INC (until Jun 4, 2015); ACCESS PHARMACEUTICALS INC (until Aug 14, 2014); CHEMEX PHARMACEUTICALS INC (until Feb 5, 1996)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.